Citation Impact
Citing Papers
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
2008
Cytokines in inflammatory bowel disease
2014 Standout
Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
1996 Standout
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas
1992
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
2004
Challenge of Chimpanzees Immunized with a Recombinant Canarypox-HIV-1 Virus
1997 StandoutNobel
Large quantity production with extreme convenience of human SDF‐1α and SDF‐1β by a Sendai virus vector
1998 StandoutNobel
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8
1995
Antibody neutralization and escape by HIV-1
2003 StandoutNature
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
2010 Standout
Parental employment at time of conception and risk of cancer in offspring
1991
Participation in Research and Access to Experimental Treatments by HIV-Infected Patients
2002
Interclade Neutralization and Enhancement of Human Immunodeficiency Virus Type 1 Identified by an Assay Using HeLa Cells Expressing Both CD4 Receptor and CXCR4/CCR5 Coreceptors
2004 StandoutNobel
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease
2004
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
How were new medicines discovered?
2011 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
Increasing incidence of childhood leukemia in Northwest Italy, 1975–98
2003
Genetic Analysis of HIV-1 during Rapid Progression to AIDS in an Apparently Healthy Man
1994
Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas
2005 StandoutNobel
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Long-term survivors of HIV-1 infection
1995
Idarucizumab for Dabigatran Reversal
2015 Standout
Lowering the Detection Limits of HIV-1 Viral Load Using Real-Time Immuno-PCR for HIV-1 p24 Antigen
2004
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro.
1997
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
2003
Men at risk: occupation and male infertility
2004 Standout
Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
2010
Obesity in children and young people: a crisis in public health
2004 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Fat distribution and gender differences in serum lipids in men and women from four European communities
1991
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
1998 Standout
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.
1995
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
2018 StandoutScience
Degree of Fatness after Treatment for Acute Lymphoblastic Leukemia in Childhood1
1999
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
Herpesviruses as Co-Factors of HIV Disease: Case not Proven
1995
Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.
1994
Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination
1999 Standout
Preparation of Porous Polysaccharides Templated by Coordination Polymer with Three-Dimensional Nanochannels
2017 StandoutNobel
Sequential coronary bypass grafts. Long-term follow-up.
1986
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease
1994
Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide‐rich de novo designed peptides
2018 StandoutNobel
Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines
1998
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals
1997
TRANSMISSIBILITY OF HUMAN IMMUNODEFICIENCY VIRUS IN HAEMOPHILIC AND NON-HAEMOPHILIC CHILDREN LIVING IN A PRIVATE SCHOOL IN FRANCE
1986 StandoutNobel
Polyoxometalates in Medicine
1998 Standout
Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection
1998
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses
1985
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
1997 StandoutScience
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
2013
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
Lowering the Detection Limits of HIV-1 Viral Load Using Real-Time Immuno-PCR for HIV-1 p24 Antigen
2004
A comparative study on the pharmacokinetics of methotrexate in a dose range of 0.5 g to 33.6 g/m2 in children with acute lymphoblastic leukemia
1987
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization
1994
Works of E. Scheibel being referenced
Clinical course of primary HIV infection: consequences for subsequent course of infection.
1989
A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A
1994
Limited Protective Effect of the CCR5Δ32/CCR5Δ32 Genotype on Human Immunodeficiency Virus Infection Incidence in a Cohort of Patients with Hemophilia and Selection for Genotypic X4 Virus
2003
Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden
1992
Incidence of Childhood Cancer in Denmark 1943–1984
1989
Increase in Percentage of CD45RO+/CD8+ Cells Is Associated with Previous Severe Primary HIV Infection
1995
Major Surgery in Haemophilic Patients with Inhibitors Using Recombinant Factor VIla
1996
Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans
1993
Alterations in T‐lymphocyte subsets among Danish haemophiliacs: Relation to source of factor VIII preparations and high dose factor VIII treatment
1984
Two new candidate mutations in type IIA von Willebrand's disease (ARG834→GLY, GLY846→ARG) and one polymorphism (TYR821→CYS) in the A2 region of the von Willebrand factor
1993
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
1994
METHOTREXATE IN THE PLASMA AND CEREBROSPINAL FLUID OF CHILDREN TREATED WITH INTERMEDIATE DOSE METHOTREXATE
1981